Source: Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. Massard (Strasbourg, France). The place of surgery in M1a disease. Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?

Member's Comments

No comment yet.

Related content which might interest you: Is surgical resection of M1a lung adenocarcinoma with metastatic pleural nodules really a useless choice? Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 The management of single metastasis in stage M1b Source: Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC? Year: 2013 Coronary artery disease and lung cancer surgery Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006 Locally advanced disease – indications and results of extended resections Source: Annual Congress 2005 - Borderline indications for surgical treatment of non-small cell lung cancer Year: 2005 Sublobar resections vs lobectomy for early stage lung cancer: where do we stand? Source: Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process? Year: 2020 Bronchoplastic lobectomy: does the disease influence on the result? Source: Eur Respir J 2003; 22: Suppl. 45, 367s Year: 2003 Occult N2 disease after surgical resection for clinical stage I NSCLC: factors affecting survival Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 The role of surgery in pleural disease Source: Eur Respir Monogr 2020; 87: 263-281 Year: 2020 Interval versus continuous training in patients with end stage lung disease before lung transplantation Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009 Indications and results of resectional surgery for limited disease Source: Annual Congress 2006 - Up to date management of bronchiectasis Year: 2006 Disease relapse after radical surgery of NSCLC Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007 Role of surgical management in oligometastatic disease Source: International Congress 2019 – New perspectives in thoracic surgical oncology Year: 2019 Is the lung emphysema contraindication to radical NSCLC surgery? Source: Eur Respir J 2001; 18: Suppl. 33, 94s Year: 2001 Would lung cancer patients benefit from prehabilitation before surgery? Selecting optimisable patient variables. Source: International Congress 2019 – All aspects of general thoracic surgery Year: 2019 Parenchyma-sparing sleeve resection in advanced nodal disease of NSCLC Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010 Persistent N2-disease after induction therapy does not jeopardize outcomes of pneumonectomy Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery Year: 2007